The Arthritis Foundation and Deerfield-based Takeda Pharmaceuticals U.S.A. launched Let’s Speak Gout, a program based on new joint research, that offers tools for health care professionals and patients to make more effective gouty arthritis management a priority.

Let’s Speak Gout includes insights from both patients and HCPs from new research that separately studied patient discussions about gout and physicians’ reactions to them, as well as physician discussions about gout and patients’ reactions to them. Program materials also reflect insights from separate Arthritis Foundation and Takeda research, as well as from other published studies conducted over the last few years. Based on all this research, the Arthritis Foundation identified important gaps and insights into how HCPs and patients think, act and talk about gout. These insights were used to develop new tools to help enhance the effectiveness of conversations between HCPs and patients with gout.

Let’s Speak Gout resources for HCPs and patients in the United States are available on the Arthritis Foundation website, www.arthritis.org/lets-speak-gout; the site includes downloadable discussion tools for HCPs and for gout patients, details on the research findings and research methodology.

Let’s Speak Gout tool content includes highlights of research findings and a guide to having more effective interactions between HCPs and patients living with gout.

For more information, visit the Let’s Speak Gout Web site. http://www.arthritis.org/lets-speak-gout.